[Changes in the energy status of the brain structures in pharmacological exposures].
Arkhipov
V I
VI
Bulantsev
A Iu
AIu
D000042:Absorption; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D003847:Deoxyglucose / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004734:Energy Metabolism / Q000187:drug effects*; D005947:Glucose / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects / Q000378:metabolism; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000378:metabolism; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology; D014851:Wakefulness / Q000187:drug effects / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D002800:Cholinesterase Inhibitors; D018377:Neurotransmitter Agents; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011954:Receptors, Dopamine; D014660:Vasoactive Intestinal Peptide; D005680:gamma-Aminobutyric Acid; D013973:Thyrotropin-Releasing Hormone; D003847:Deoxyglucose; D005947:Glucose
Izmenenie énergeticheskogo sostoianiia struktur mozga pri farmakologicheskikh vozdeĭstviiakh.